Realcan Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 1/6
Realcan Pharmaceutical Group is a dividend paying company with a current yield of 0.4% that is well covered by earnings.
Key information
0.4%
Dividend yield
0.05%
Buyback Yield
| Total Shareholder Yield | 0.4% |
| Future Dividend Yield | n/a |
| Dividend Growth | -1.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.013 |
| Payout ratio | 49% |
Recent dividend and buyback updates
Recent updates
Realcan Pharmaceutical Group (SZSE:002589) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 06
Improved Revenues Required Before Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) Stock's 36% Jump Looks Justified
Oct 18Realcan Pharmaceutical Group's (SZSE:002589) Earnings Seem To Be Promising
May 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002589's dividend payments have been volatile in the past 10 years.
Growing Dividend: 002589's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| Realcan Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002589) | 0.4% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Healthcare) | 1.7% |
| Analyst forecast (002589) (up to 3 years) | n/a |
Notable Dividend: 002589's dividend (0.4%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 002589's dividend (0.4%) is low compared to the top 25% of dividend payers in the CN market (2.12%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (49.1%), 002589's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 002589 is paying a dividend but the company has no free cash flows.